The IMAO-B MDL 72.974 A in Parkinson's disease.
Marconi
R
R
Bonnet
A M
AM
Vidailhet
M
M
Agid
Y
Y
D000498:Allyl Compounds; D002082:Butylamines / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D000498:Allyl Compounds; D002082:Butylamines; D008996:Monoamine Oxidase Inhibitors; C058000:mofegiline; D007980:Levodopa